Jornadal, Misonilyn .
HRN: 22-91-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2023
CEFUROXIME 1.5GM (VIAL)
06/02/2023
06/08/2023
IV
1.5 G
On Call To OR
For Repeat CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes